One hundred twenty eyes of 120 consecutive and eligible subjects (60 patients with glaucoma and 60 healthy control subjects) were included in this cross-sectional study. The study was approved by our institutional review board and complied with the tenets of Declaration of Helsinki. Informed consent was obtained. All subjects were 40 years of age or older, having a best-corrected visual acuity of ≥20/40 and a refractive error within ±6.0 D (spherical equivalent).
Eligible subjects underwent a complete ophthalmic evaluation, including review of medical history, manifest refraction, axial length (EchoScan US 3300; Nidek Corp., Gamagori, Japan), keratometry, central corneal pachymetry, slit lamp biomicroscopy, intraocular pressure (IOP) measurement using Goldmann applanation tonometry, gonioscopy, dilated fundus evaluation using a +90-D lens and automated perimetry (model 745 Humphrey visual field analyser [HFA], full-threshold program 30-2; Carl Zeiss Meditec, Inc.). OCT and HRT scanning was also performed within 1 week of the baseline examinations.
Normal control subjects had no ocular complaints or diseases. All had normal anterior segments on slit lamp biomicroscopy, open angles on gonioscopy and normal disc and macula. They also had IOP ≤21 mm Hg and reliable normal (mean deviation and pattern SD within 95% confidence limits and a Glaucoma Hemifield Test (GHT) result within normal limits full-threshold 30-2 Humphrey visual fields on more than two occasions. One eye of 60 such subjects was randomly selected for inclusion in the study.
Patients were categorized as having glaucoma if they had an IOP of >21 mm Hg and reliable, consistent glaucomatous visual field defects commensurate with optic nerve damage on more than two occasions. Glaucomatous visual field loss was defined as consistent presence of a cluster of three or more nonedge points on the pattern deviation plot in typical glaucomatous locations, CPSD with
P < 5%, or a GHT outside normal limits. Sixty such eyes of 60 patients having early or moderate visual field defects according to the Hodapp-Anderson-Parrish
23 grading scale of visual field severity were included in the study.
Patients who had other intraocular or neurologic disease that affected the RNFL or optic disc, a secondary cause of raised intraocular pressure, or significant media opacity were excluded. Eyes with consistently unreliable visual field results (defined as false positives and negatives >33% and fixation losses >20%) were also excluded from the study.
All CSLO scans were performed with the HRT II (Heidelberg Retinal Tomograph; software ver. 2.0). A series of three good-quality scans for each eye were used for the ONH analysis. The following parameters were computed: disc area, cup area, rim area, cup-to-disc (C-D) area ratio, rim-to-disc (R-D) area ratio, vertical and horizontal C-D ratio and cup volume. Linear discriminant functions (LDF) developed by Mikelberg et al.
24 (FSM) and Bathija et al.
25 (RB), and the Moorfield regression analysis (MRA)
26 inbuilt in the HRT II were also evaluated in the study.
The OCT 3 (StratusOCT 3000; software version 4.0; Carl Zeiss Meditec, Inc.) was used to image the RNFL and the ONH. A masked operator performed imaging with the two algorithms at the same session. Disc area, cup area, rim area, C-D area ratio, horizontal and vertical C-D ratio, vertical integrated rim area (VIRA, estimate of total volume of rim tissue calculated by multiplying the average of individual rim areas by the circumference of the disc), and horizontal integrated rim width (HIRW, estimate of total area of rim tissue calculated by multiplying the average of individual rim widths by the circumference of the disc) were the ONH parameters evaluated.
The Fast RNFL Thickness protocol on OCT was used to yield three 3.4-mm-diameter circular scans for each eye. Presence of uniform signal intensity, strong reflectance signal from the RNFL and the retinal pigment epithelium resulting in clear demarcation of both layers without the absence of any part of image constituted a good-quality scan. The following parameters were calculated: average RNFL thickness, RNFL thickness in the superior and inferior hemifields, RNFL thickness in the four quadrants spanning 90° each and RNFL thickness in twelve 30° clock-hour sectors.
One-way ANOVA with the Bonferroni correction was used to compare the glaucoma parameters between the groups and between diagnostic modalities within each group. Receiver operator curves (ROC) were plotted for each parameter to evaluate its diagnostic ability. Linear discriminant analysis (LDA), artificial neural network (ANN), and classification and regression tree (CART) methods were used to develop three automated classifiers based on the glaucoma parameters measured by the OCT. Discriminant analysis was performed using all the ONH and RNFL variables to develop the best linear discriminant function (LDF). LDA has been used in various glaucoma studies
27 28 for classifying patients according to disease severity. It assumes a Gaussian distribution of data and defines linear discrimination boundaries between the categories where it maximizes the variance between classes while minimizing the variance within classes. Neural network analysis mimics the brain’s problem-solving process. Just as humans apply knowledge gained from experience to new problems or situations, a neural network takes previously solved examples to build a system of “neurons” that make new decisions, classifications, and forecasts. It looks for patterns in training sets of data, learns these patterns, and develops the ability to classify new patterns correctly.
29 The CART method is unique in its methodology by making no previous assumptions in labeling a subject as normal or diseased.
30 The key elements of a CART analysis are a set of rules for splitting each node in a tree, deciding when a tree is complete, assigning each terminal node to a class outcome, and selecting the “right-sized” tree. All the ONH and RNFL parameters were simultaneously entered into the CART analysis software, to obtain the best classification tree based on minimum variables. Cross-validation of the LDA and ANN results was performed by randomly selecting 70% of the study population as a training set and the remaining 30% as the test set. Sensitivities and specificities of such a set were calculated. This process was repeated 10 times, and the average values were compared with the results initially obtained. Twenty-five-fold cross-validation was performed for CART analysis by omitting one twenty-fifth of the data for each series. Misclassification rates and ROCs were plotted to compare the classifiers’ performance with one another and with the HRT-based algorithms in discriminating glaucomatous from normal eyes.